跳至主要内容
临床试验/JPRN-UMIN000010307
JPRN-UMIN000010307已完成未知

A study to evaluate the safety and efficacy of tolvaptan in acute heart failure with hypoalbuminemia - A study to evaluate the safety and efficacy of tolvaptan in acute heart failure with hypoalbuminemia

Showa University Northern Yokohama Hospital0 个研究点目标入组 40 人开始时间: 2013年3月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)history of allergy against this drug or similar compounds (2)anuria (urine volume <100ml/day) (3)subjects who cannot feel thirsty or have difficulty to drink (4)subjects whose serum sodium level is over 147mEq/L (5)subjects who are pregnant or possibly pregnant (6)serum creatinine>1.5mg/dL (7)subjects who already have tolvaptan at the entry (8)acute coronary syndrome (9)patients who are judged to be inappropriate to this study

研究者

发起方
Showa University Northern Yokohama Hospital

相似试验